Ulrike Garske‐Román
-
- Radiopharmaceutical Chemistry and Applications 8
- Medical Imaging Techniques and Applications 5
- Monoclonal and Polyclonal Antibodies Research 1
- Neurology top 5%
- Neuroblastoma Research and Treatments 9
- Oncology top 5%
- Lung Cancer Research Studies 12
- HER2/EGFR in Cancer Research 1
- Epidemiology top 5%
- Neuroendocrine Tumor Research Advances 15
- Radiation top 5%
- Advanced Radiotherapy Techniques 2
- Co-authors
- Mattias SandströmAnders SundinDonald GranbergMark LubberinkBarbro ErikssonHans LundqvistSilvia JohanssonEzgi Ilan
In The Last Decade
Ulrike Garske‐Román
19 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 55
- Radiology, Nuclear Medicine and Imaging 749
- Neurology 416
- Oncology 679
- Epidemiology 663
- Radiation 114
Countries citing papers authored by Ulrike Garske‐Román
This map shows the geographic impact of Ulrike Garske‐Román's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Garske‐Román with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Garske‐Román more than expected).
Fields of papers citing papers by Ulrike Garske‐Román
This network shows the impact of papers produced by Ulrike Garske‐Román. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Garske‐Román. The network helps show where Ulrike Garske‐Román may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ulrike Garske‐Román, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 5 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 1 | |
| 4 | 2021 | 33 | |
| 5 | 2020 | 37 | |
| 6 | 2019 | 35 | |
| 7 | 2019 | 55 | |
| 8 | 2018 | 176 | |
| 9 | 2017 | 27 | |
| 10 | Fractional contribution of extrapolations after 96 h in absorbed dose calculation to kidneys in 450 patients with neuroendocrine tumours receiving Lu-177-DOTATATE therapy | 2015 | 1 |
| 11 | 2015 | 38 | |
| 12 | 2015 | 32 | |
| 13 | 2015 | 170 | |
| 14 | 2014 | 205 | |
| 15 | 2013 | 2 | |
| 16 | 2013 | 115 | |
| 17 | 2013 | 134 | |
| 18 | 2012 | 1 | |
| 19 | 2012 | 204 |
About Ulrike Garske‐Román
Ulrike Garske‐Román is a scholar working on Neurology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (15 papers), Lung Cancer Research Studies (12 papers), Neuroblastoma Research and Treatments (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Medical Imaging Techniques and Applications (5 papers), Advanced Radiotherapy Techniques (2 papers), HER2/EGFR in Cancer Research (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (749 citations), Neurology (416 citations) and Oncology (679 citations). Ulrike Garske‐Román has collaborated with scholars based in Sweden, Norway and Israel. Frequent co-authors include Mattias Sandström, Anders Sundin, Donald Granberg, Mark Lubberink, Barbro Eriksson, Hans Lundqvist, Silvia Johansson, Ezgi Ilan, Jens Sørensen and Irina Velikyan. Their work appears in journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging and Advances in experimental medicine and biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.